WPP Group PLC
07 January 2005
For Immediate Release 7 January 2005
WPP GROUP PLC ("WPP")
Sudler & Hennessey acquires Current Medical Directions in the US
WPP announces that its wholly-owned operating company Sudler & Hennessey
("S&H"), the global healthcare marketing and communications network within the
Young & Rubicam Brands group, has acquired Current Medical Directions ("CMD") in
the US, a leader in the medical communications industry.
Founded in 1990, CMD employs 77 people and is headquartered in New York.
Specialising in educational programs for healthcare professionals and patients,
CMD's clients include Aventis, Bristol-Meyers Squibb, Eisai, GlaxoSmithKline and
Pfizer.
CND had net revenues of US$17.2 million for the year ended 31 December 2003 and
net assets of US$1.6 million as at the time of closing.
This investment continues WPP's strategy of developing its networks in important
and fast-growing markets and sectors.
For further information please contact:
Feona McEwan, WPP 44-20 7408 2204
www.wpp.com
www.sudler.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.